Form 4 for RMD ResMed|
Accepted 2022-10-17 00:00:00 ET · period of report 2022-10-14 · accession 0001127602-22-023989 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-17 | 2022-10-14 | RMD | Douglas Robert Andrew | Pres, COO | S - Sale+OE | $215.09 | -11.4K | 35.1K | -24% | -$2.44M |
| DM | 2022-10-17 | 2022-10-14 | RMD | Douglas Robert Andrew | Pres, COO | M - OptEx | $58.24 | +18.0K | 46.4K | +63% | +$1.05M |
| DM | 2022-10-17 | 2022-10-14 | RMD | Douglas Robert Andrew | Pres, COO | M - OptEx | $0.00 | -18.0K | 34.9K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2022-10-14 | S | D | 11,355 | $215.09 | 35,086 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $213.62 to $217.36. The price reported above reflects the weighted average sale price. |
| 2 | Common | ResMed Common Stock | 2022-10-14 | M | A | 1,145 | $58.24 | 29,553 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2022-10-14 | M | A | 16,888 | $58.24 | 46,441 | D | — | — | |
| 4 | Derivative | ResMed Common Stock Options | 2022-10-14 | M | D | 16,888 | $0.00 | 18,032 | D | $58.24 · 2016-11-11 to 2022-11-19 | 16,888 ResMed Common Stock | (F3) Represents date options first became exercisable. Options vest 1/3 per year. |
| 5 | Derivative | ResMed Common Stock Options | 2022-10-14 | M | D | 1,145 | $0.00 | 34,920 | D | $58.24 · 2016-11-11 to 2022-11-19 | 1,145 ResMed Common Stock | (F3) Represents date options first became exercisable. Options vest 1/3 per year. |